Farms.com Home   News

CN To Invest $95 Million In Manitoba

CN Rail has announced plans to invest approximately $95 million in Manitoba in 2021 as part of CN’s $3 billion capital investment plan across its network.

In Manitoba, CN’s investment will focus on technology and infrastructure maintenance to enhance safety and the fluidity of its network.

Maintenance program highlights include:

Replacing 29 miles of rail;
Installing approximately 118,000 new railroad ties;
Rebuilding 17 road crossing surfaces; and
Maintenance work on bridges, culverts, signal systems, and other track infrastructure

In a news release, CN Rail says the proposed end-to-end merger between CN and Kansas City Southern will create a transportation network across North America, enhancing competition, spurring economic growth and delivering benefits to the local communities in which both railroads operate.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.